OSE Immunotherapeutics Overview

  • Founded
  • 2004
Founded
  • Status
  • Public
  • Employees
  • 42
Employees
  • Stock Symbol
  • OSE
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $14.16
  • (As of Tuesday Closing)

OSE Immunotherapeutics General Information

Description

OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
PAR
Primary Office
  • 22, Boulevard Benoni Goullin
  • 44200 Nantes
  • France
+33 02 00 00 00 00

OSE Immunotherapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OSE Immunotherapeutics Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$14.16 $14.55 $4.68 - $19.16 $254M 18M 204K -$1.21

OSE Immunotherapeutics Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 155,288 155,288 39,613 40,803
Revenue 11,876 11,876 29,052 28,860
EBITDA (20,809) (20,809) (975) 5,870
Net Income (18,871) (18,871) (5,208) 6,479
Total Assets 119,274 119,274 99,620 87,970
Total Debt 24,002 24,002 12,865 5,101
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OSE Immunotherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OSE Immunotherapeutics‘s full profile, request access.

Request a free trial

OSE Immunotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immu
Biotechnology
Nantes, France
42 As of 2019
000.00
000000000 000.00

000000 0

incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ull
0000000000000
Plymouth Meeting, PA
000 As of 0000
000.00
00000000 000.00

000000 0

em ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et
0000000000000
Cambridge, MA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OSE Immunotherapeutics Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
000000000 Venture Capital-Backed Berlin, Germany 00 00000 000000000000 00000
0000000000 Venture Capital-Backed Abingdon, United Kingdom 000 00.000 00000000 00.000
You’re viewing 5 of 42 competitors. Get the full list »

OSE Immunotherapeutics Executive Team (7)

Name Title Board Seat Contact Info
Alexis Peyroles Chief Executive Officer & Director
Anne-Laure Autret-Cornet Chief Financial Officer
Nicolas Poirier Chief Scientific Officer & Board Member
Dominique Costantini Ph.D Co-Founder, Chairman and Director of Development
Maryvonne Hiance Vice Chairman & Director of Public Affairs
You’re viewing 5 of 7 executive team members. Get the full list »

OSE Immunotherapeutics Board Members (8)

Name Representing Role Since
000000 00000000 OSE Immunotherapeutics Chief Executive Officer & Director 000 0000
00000000 00é00 00.0 Self Board Member 000 0000
0000-0000000 000000000 Self Board Member 000 0000
000000000 000000 Self Vice Chairman & Director of Public Affairs 000 0000
0000000 0000000 OSE Immunotherapeutics Chief Scientific Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

OSE Immunotherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OSE Immunotherapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OSE Immunotherapeutics‘s full profile, request access.

Request a free trial

OSE Immunotherapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 24-Feb-2016 000000000000000000 000.00 Pharmaceuticals 000000000 0000000000 00.0
To view OSE Immunotherapeutics’s complete acquisitions history, request access »